|
Volumn 11, Issue 3, 1998, Pages 187-188
|
Antifungal drugs: The new frontier: Editorial;Antifungicos: La nueva frontera
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANIDULAFUNGIN;
ANTIFUNGAL AGENT;
CASPOFUNGIN;
N ACETYLGLUCOSAMINE;
VORICONAZOLE;
ANTIINFECTIVE AGENT;
ANTITRYPANOSOMAL AGENT;
CYCLOPEPTIDE;
PEPTIDE;
POSACONAZOLE;
PYRIMIDINE DERIVATIVE;
TRIAZOLE DERIVATIVE;
ANTIFUNGAL ACTIVITY;
ASPERGILLUS;
CANDIDA;
CRYPTOCOCCUS;
DRUG EFFICACY;
EDITORIAL;
FUSARIUM;
HOSPITALIZATION;
MYCOSIS;
PNEUMOCYSTIS CARINII;
ANTIBIOTIC RESISTANCE;
DRUG EFFECT;
FEMALE;
FUNGUS;
HUMAN;
MALE;
RESEARCH;
VAGINA CANDIDIASIS;
ANTI-BACTERIAL AGENTS;
ANTIBIOTICS, ANTIFUNGAL;
ANTIFUNGAL AGENTS;
CANDIDIASIS, VULVOVAGINAL;
DRUG RESISTANCE, MICROBIAL;
FEMALE;
FUNGI;
HUMANS;
MALE;
MYCOSES;
PEPTIDES;
PEPTIDES, CYCLIC;
PYRIMIDINES;
RESEARCH;
TRIAZOLES;
TRYPANOCIDAL AGENTS;
|
EID: 0031732760
PISSN: 02143429
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
Times cited : (3)
|
References (0)
|